Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous mesenchymal stem cells with beta-tricalcium phosphate for large skeletal defects during revision total hip arthroplasty
2012-005599-33Phase 2Completed
- Sponsor
- Charles University Faculty of Medicine in Hradec Králové
- Start
- Feb 2013
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous mesenchymal stem cells in Aseptic loosening (AL), Bone defect, sponsored by Charles University Faculty of Medicine in Hradec Králové. Started Feb 2013; status: completed.
02
Drugs
autologous mesenchymal stem cells
03
Conditions
Aseptic loosening (AL)Bone defect
Beyond the preview
Go deeper on 2012-005599-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005599-33.